
Opinion|Videos|October 18, 2024
Addressing Unmet Needs in ART
Author(s)Jeffrey Dunn, PharmD, MBA
Jeffrey Dunn, Pharm.D., MBA, discusses how key unmet needs in assisted reproductive technology (ART) programs drive ongoing research and innovation, fostering hope for a future where fertility treatments are more effective, accessible and tailored to individual patient needs.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Inside the DUPLEX Trial: FSGS Design, Endpoints, and Exclusions
2
Corticosteroids, RAS Inhibitors, or Sparsentan First for FSGS?
3
Prior authorization isn’t shrinking. Its savings are
4
David Chen, Pharm.D., on Kaiser Permanente's biosimilar strategy
5
























